Exact Mass: 366.0943
Exact Mass Matches: 366.0943
Found 119 metabolites which its exact mass value is equals to given mass value 366.0943,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Atovaquone
Atovaquone is only found in individuals that have used or taken this drug. It is a hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols. [PubChem]Atovaquone is a hydroxy- 1, 4- naphthoquinone, an analog of ubiquinone, with antipneumocystis activity. The mechanism of action against Pneumocystis carinii has not been fully elucidated. In Plasmodium species, the site of action appears to be the cytochrome bc1 complex (Complex III). Several metabolic enzymes are linked to the mitochondrial electron transport chain via ubiquinone. Inhibition of electron transport by atovaquone will result in indirect inhibition of these enzymes. The ultimate metabolic effects of such blockade may include inhibition of nucleic acid and ATP synthesis. Atovaquone also has been shown to have good in vitro activity against Toxoplasma gondii. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D004791 - Enzyme Inhibitors
Furocoumarinic acid glucoside
Furocoumarinic acid glucoside is found in fruits. Furocoumarinic acid glucoside is reported from Ficus carica (fig
2-(2-Chlorophenyl)-4-methyl-5-(pyridin-2-ylmethyl)-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione
GKT136901 is a potent, selective and orally active inhibitor of NADPH oxidase (NOX1/4), with Kis of 160 and 165 nM, respectively. GKT136901 is also a selective and direct scavenger of peroxynitrite. GKT136901 can be used for the research of diabetic nephropathy, stroke, and neurodegeneration. GKT136901 also has anti-inflammatory activity[1][2][3].
3-[4-(4-Chlorophenyl)cyclohexyl]naphthalene-1,2,4-trione
5-((4-(2-(1H-Indol-1-yl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
Pirinixil
Psoralenoside
7,7,8,8-Tetrakis(methoxydiazenyl)bicyclo[4.2.0]octa-1(6),3-diene-2,5-dione
rel-(5R,6S,7S,8R)-8-chloro-5,6,7,8-tetrahydro-5,6,7-trihydroxy-2-[2-(4-methoxyphenyl)ethyl]-4H-1-benzopyran-4-one
3,5-dihydroxy-2-methyl-1,4-naphthoquinone 5-O-beta-glucoside|droserone 5-O-beta-glucoside
2-oxo-2H-chromen-7-yl 6-O-acetyl-beta-D-glucopyranoside|7-O-(6-acetoxy-beta-D-glucopyranosyl)coumarin
Psoralenoside
Psoralenoside is a natural product found in Cullen corylifolium with data available. Psoralenoside is a benzofuran glycoside from Psoralea corylifolia[1]. Psoralenoside exhibits high binding affinities against histaminergic H1, calmodulin, and voltage-gated L-type calcium channels (E-value≥-6.5 Kcal/mol)[2]. Psoralenoside?shows estrogen-like activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity[3]. Psoralenoside is a benzofuran glycoside from Psoralea corylifolia[1]. Psoralenoside exhibits high binding affinities against histaminergic H1, calmodulin, and voltage-gated L-type calcium channels (E-value≥-6.5 Kcal/mol)[2]. Psoralenoside?shows estrogen-like activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity[3]. Psoralenoside is a benzofuran glycoside from Psoralea corylifolia[1]. Psoralenoside exhibits high binding affinities against histaminergic H1, calmodulin, and voltage-gated L-type calcium channels (E-value≥-6.5 Kcal/mol)[2]. Psoralenoside?shows estrogen-like activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity[3].
Isopsoralenoside
Isopsoralenoside is a natural product found in Cullen corylifolium with data available. Isopsoralenoside is a benzofuran glycoside from Psoralea corylifolia. Isopsoralenoside can be quickly metabolized to Psoralen (HY-N0053) in digestive tract contents. Isopsoralenoside?show estrogen-like activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity[1]. Isopsoralenoside is a benzofuran glycoside from Psoralea corylifolia. Isopsoralenoside can be quickly metabolized to Psoralen (HY-N0053) in digestive tract contents. Isopsoralenoside?show estrogen-like activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity[1].
Rubinaphthin A
Rubinaphthin A is a natural product found in Rubia yunnanensis with data available.
ATOVAQUONE
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D004791 - Enzyme Inhibitors
1-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynaphthalene-2-carboxylic acid
C17H18O9_2-Propenoic acid, 3-[4-(beta-D-glucopyranosyloxy)-5-benzofuranyl]-, (2E)
1-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynaphthalene-2-carboxylic acid
fluroxypyr-meptyl
CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5185; ORIGINAL_PRECURSOR_SCAN_NO 5184 CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5213; ORIGINAL_PRECURSOR_SCAN_NO 5211 CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4609; ORIGINAL_PRECURSOR_SCAN_NO 4607 CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5197; ORIGINAL_PRECURSOR_SCAN_NO 5195 CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5209; ORIGINAL_PRECURSOR_SCAN_NO 5208 CONFIDENCE standard compound; INTERNAL_ID 1295; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5216; ORIGINAL_PRECURSOR_SCAN_NO 5212
Ala Ala Cys Cys
Ala Cys Ala Cys
Ala Cys Cys Ala
Cys Ala Ala Cys
Cys Ala Cys Ala
Cys Cys Ala Ala
Cys Gly Gly Met
Cys Gly Met Gly
Cys Met Gly Gly
Gly Cys Gly Met
Gly Cys Met Gly
Gly Gly Cys Met
Gly Gly Met Cys
Gly Met Cys Gly
Gly Met Gly Cys
Met Cys Gly Gly
Met Gly Cys Gly
Met Gly Gly Cys
Furocoumarinic acid glucoside
4-(?-D-Glucopyranosyloxy)-1-hydroxy-2-naphthoic acid
(5-nitro-1-benzothiophen-2-yl)-(4-phenylpiperidin-1-yl)methanone
TERT-BUTYL 7-BROMOSPIRO[INDOLINE-3,4-PIPERIDINE]-1-CARBOXYLATE
Pirinixil
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
TERT-BUTYL 5-BROMOSPIRO[INDOLINE-3,4-PIPERIDINE]-1-CARBOXYLATE
Benzoic acid, 4,4-(1,4-phenylenedi-2,1-ethynediyl)bis-
4-(2,5-dioxopyrrol-1-yl)-N-[2-[3-(trifluoromethyl)diazirin-3-yl]phenyl]butanamide
7-Amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenylmethyl ester
6β-[2-(4-hydroxy-phenoxy)-acetylamino]-penicillanic acid
DANSYL-L-ASPARTIC ACID DI(CYCLOHEXYLAMMONIUM) SALT
4-[(4-Imidazo[1,2-A]pyridin-3-ylpyrimidin-2-YL)amino]benzenesulfonamide
N-(4-fluorophenyl)-3-([1,2,4]triazolo[4,3-a]quinolin-1-ylthio)propanamide
3-(3-Oxo-2-benzo[f][1]benzopyranyl)-1-phenyl-4-pyrazolecarboxaldehyde
(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate
2-[4-(4-Chlorophenyl)cyclohexylidene]-3,4-dihydroxy-1(2H)-naphthalenone
7,7,8,8-Tetrakis(methoxydiazenyl)bicyclo[4.2.0]octa-1(6),3-diene-2,5-dione
4-[(2,4-dichlorophenoxy)methyl]-N-[2-(dimethylamino)ethyl]benzamide
1-(3-Amino-7-methoxy-1-pyrazolo[3,4-b]quinolinyl)-2-(4-chlorophenyl)ethanone
2-Methoxy-4-[(8-methoxy-4,5-dihydro-naphtho[1,2-d]thiazol-2-ylimino)-methyl]-phenol
4-(Dimethylsulfamoyl)benzoic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester
3,5,7-Trihydroxy-2-(1-hydroxy-3-methoxy-4-oxocyclohexyl)-6-methoxychromen-4-one
3-[4-(4-Chlorophenyl)cyclohexyl]naphthalene-1,2,4-trione
HT-2157
HT-2157 (SNAP 37889) is a selective, high-affinity, competitive antagonists of galanin-3 receptor (Gal3).
OSS_128167
OSS_128167 is a potent selective sirtuin 6 (SIRT6) inhibitor with IC50s of 89 μM, 1578 μM and 751 μM for SIRT6, SIRT1 and SIRT2, respectively. OSS_128167 has anti-HBV activity that inhibits HBV transcription and replication. OSS_128167 has anti-cancer, anti-inflammation and anti-viral effects[1][2].
SIRT6-IN-2
SIRT6-IN-2 (Compound 5) is a selective SIRT6 inhibitor (IC50: 34 μM). SIRT6-IN-2 increases acetylation of H3K9 and increases glucose uptake in cultured cells. SIRT6-IN-2 also reduces T cell proliferation. SIRT6-IN-2 has immunosuppressive and chemosensitizing effects[1].
